Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanqi Shengban Tang
- Development stage
- Phase 4
- Lead developer
- Shanghai Municipal Health Commission
- Administration
- Oral
01
Overview
Sanqi Shengban Tang is a traditional Chinese herbal medicine, specifically a decoction, formulated as granule pieces. It is currently being investigated in clinical trials for its efficacy and safety in the management of Immune Thrombocytopenia.
- Other names
- 三七升板汤颗粒饮片SQSB decoctionChinese herbal granule pieces of SQSB decoction
Beyond the preview
Go deeper on Sanqi Shengban Tang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanqi Shengban Tang.